Dr. Ferrer BioPharma Named Finalist for CPhI Pharma Awards 2023
Dr. Ferrer BioPharma (DFB) is honored to be a finalist for the prestigious CPhI Pharma Worldwide Awards 2023 , an internationally renowned award platform organized by CPhI, the world's leading pharmaceutical networking event.
- Dr. Ferrer BioPharma (DFB) is honored to be a finalist for the prestigious CPhI Pharma Worldwide Awards 2023 , an internationally renowned award platform organized by CPhI, the world's leading pharmaceutical networking event.
- Dr. Gustavo Ferrer , founder of DFB, shared, "Being shortlisted by CPhI is a testament to our unwavering commitment to patient-focused innovation in addressing respiratory illnesses like COVID-19, influenza, post-COVID syndrome, and allergies."
- The nozzle was carefully engineered to optimize nasal drug target delivery and maximize patient comfort.
- The team also validated the specific angle of application for the treatment of viral illnesses and allergies.